ArticleBMC medicine2023

A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE).

Lixin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.